Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 9.12 USD -1.46%
Market Cap: 61m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+6%
Revenue
Forecast
+3%
Operating Income
Forecast
+5%
Net Income
Forecast
+20%

Wall Street
Price Targets

ATRA Price Targets Summary
Atara Biotherapeutics Inc

Wall Street analysts forecast ATRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRA is 15.64 USD with a low forecast of 11.11 USD and a high forecast of 18.9 USD.

ATRA Lowest Forecast
Wall Street Target
11.11 USD
22% Upside
ATRA Average Forecast
Wall Street Target
15.64 USD
71% Upside
ATRA Highest Forecast
Wall Street Target
18.9 USD
107% Upside
Lowest
Price Target
11.11 USD
22% Upside
Average
Price Target
15.64 USD
71% Upside
Highest
Price Target
18.9 USD
107% Upside
Atara Biotherapeutics Inc Competitors:
Price Targets
BRNS
Barinthus Biotherapeutics PLC
359% Upside
300676
BGI Genomics Co Ltd
2% Upside
BEAM
Beam Therapeutics Inc
146% Upside
I
688382
InventisBio Co Ltd
18% Downside
BRNS
Barinthus Biotherapeutics PLC
359% Upside
300676
BGI Genomics Co Ltd
2% Upside
BEAM
Beam Therapeutics Inc
146% Upside
I
688382
InventisBio Co Ltd
18% Downside
ELUT
Elutia Inc
284% Upside
PBYI
Puma Biotechnology Inc
21% Upside
E
1952
Everest Medicines Ltd
1% Downside
ONCO
Oncopeptides AB
279% Upside

Revenue
Forecast

Revenue Estimate
Atara Biotherapeutics Inc

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 3 years is -43%.

N/A
Past Growth
-43%
Estimated Growth
Estimates Accuracy
-41%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss
What are analyst estimates?

See Also

Summary
ATRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATRA stock valuation using valuation multiples.
Wall Street Estimates
ATRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRA's stock price target?
Price Target
15.64 USD

According to Wall Street analysts, the average 1-year price target for ATRA is 15.64 USD with a low forecast of 11.11 USD and a high forecast of 18.9 USD.

What is Atara Biotherapeutics Inc's Revenue forecast?
Projected CAGR
-43%

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 3 years is -43%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.